Evonik Industries AG (EVK) Receives €33.87 Consensus Price Target from Brokerages

Evonik Industries AG (FRA:EVK) has been given a consensus rating of “Hold” by the twenty ratings firms that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is €33.87 ($40.32).

Several equities analysts have recently commented on the stock. Societe Generale set a €39.00 ($46.43) price target on shares of Evonik Industries and gave the stock a “buy” rating in a research report on Thursday, January 11th. Barclays set a €34.50 ($41.07) target price on shares of Evonik Industries and gave the company a “buy” rating in a research report on Friday, September 29th. Deutsche Bank set a €32.00 ($38.10) target price on shares of Evonik Industries and gave the company a “neutral” rating in a research report on Thursday, September 28th. Credit Suisse Group set a €34.30 ($40.83) target price on shares of Evonik Industries and gave the company a “buy” rating in a research report on Tuesday, September 26th. Finally, Warburg Research set a €38.70 ($46.07) target price on shares of Evonik Industries and gave the company a “buy” rating in a research report on Wednesday, January 10th.

Evonik Industries (EVK) traded up €0.44 ($0.52) on Monday, reaching €31.69 ($37.73). 1,500 shares of the company’s stock traded hands. The stock has a market capitalization of $14,790.00 and a P/E ratio of 20.18. Evonik Industries has a 12 month low of €26.78 ($31.88) and a 12 month high of €32.97 ($39.25).

TRADEMARK VIOLATION WARNING: This news story was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://weekherald.com/2018/01/18/evonik-industries-ag-evk-receives-33-87-consensus-price-target-from-brokerages.html.

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply